Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (2): 123-128    DOI: 10.19485/j.cnki.issn2096-5087.2022.02.004
  论著 本期目录 | 过刊浏览 | 高级检索 |
浙江省农村2型糖尿病患者糖化血红蛋白控制水平及影响因素分析
周晓燕, 胡如英, 何青芳, 潘劲, 龚巍巍, 陆凤, 王蒙, 钟节鸣
浙江省疾病预防控制中心慢性非传染性疾病预防控制所,浙江 杭州 310051
Glycosylated hemoglobin control and its influencing factors amongpatients with type 2 diabetes mellitus in rural communitiesof Zhejiang Province
ZHOU Xiaoyan, HU Ruying, HE Qingfang, PAN Jin, GONG Weiwei, LU Feng, WANG Meng, ZHONG Jieming
Department of Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Controland Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(832 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解浙江省农村2型糖尿病(T2DM)患者的糖化血红蛋白(HbA1c)控制水平及其影响因素,为优化社区糖尿病患者管理提供依据。方法 选取浙江省嘉善县、遂昌县所有社区和永康市6个社区2016年登记在册并接受规范化管理的常住成人T2DM患者为研究对象,通过居民健康档案和慢性病管理系统收集研究对象的人口学信息;测量身高、体重、腰围和血压,实验室检测HbA1c和血脂指标;分析T2DM患者HbA1c控制(<7%)水平并采用多因素logistic回归模型分析HbA1c控制的影响因素。结果 纳入T2DM患者10 339例,其中男性4 520例,占43.72%;女性5 819例,占56.28%。年龄为(63.54±9.78)岁。糖尿病病程为(6.36±4.73)年。HbA1c控制率为47.89%。多因素logistic回归分析结果显示,男性(OR=1.123,95%CI:1.024~1.233)、地区(遂昌,OR=2.413,95%CI:2.106~2.765;永康,OR=2.460,95%CI:2.188~2.767)、病程(5~<10年,OR=1.724,95%CI:1.504~1.977;≥10年,OR=2.881,95%CI:2.477~3.351)、使用降糖药(OR=1.203,95%CI:1.089~1.329)、有慢性并发症(OR=1.190,95%CI:1.027~1.379)、血压未控制(OR=1.140,95%CI:1.030~1.261)、血脂未控制(OR=1.258,95%CI:1.104~1.433)和吸烟(OR=1.318,95%CI:1.165~1.491)与T2DM患者HbA1c控制存在统计学关联。结论 浙江省农村T2DM患者HbA1c控制率为47.89%,应重点关注经济水平较低地区、男性、病程长、使用降糖药、有慢性并发症、吸烟、血压和血脂未控制患者的HbA1lc控制水平。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
周晓燕
胡如英
何青芳
潘劲
龚巍巍
陆凤
王蒙
钟节鸣
关键词 2型糖尿病糖化血红蛋白农村    
AbstractObjective To investigate the degree and influencing factors of glycosylated hemoglobin ( HbA1c ) control among patients with type 2 diabetes ( T2DM ) living in rural communities of Zhejiang Province, so as to provide the reference for optimizing the management of diabetes patients in rural communities. Methods Permanent adult patients with T2DM that were registered and received standardized management in all communities of Jiashan County and Suichang County, and 6 communities of Yongkang City, Zhejiang Province in 2016 were recruited, and their demographic characteristics were captured from the health record system and chronic disease management system. The height, body weight, waist circumstance and blood pressure were measured, and HbA1c and blood lipid parameters were detected. The degree of HbA1c control ( <7% ) was analyzed, and its influencing factors were identified using a multivariable logistic regression model. Results A total of 10 339 patients with T2DM were enrolled, including 4 520 men ( 43.72% ) and 5 819 women ( 56.28% ), with a mean age of ( 63.54±9.78 ) years and the mean course of diabetes of ( 6.36±4.73 ) years. The rate of HbA1c control was 47.89%. Multivariable logistic regression analysis showed that males ( OR=1.123, 95%CI: 1.024-1.233 ), region ( Suichang, OR=2.413, 95%CI: 2.106-2.765; Yongkang, OR=2.460, 95%CI: 2.188-2.767 ), course of disease ( 5-9 years, OR=1.724, 95%CI: 1.504-1.977; 10 years and longer, OR=2.881, 95%CI: 2.477-3.351 ), use of hypoglycemic drugs ( OR=1.203, 95%CI: 1.089-1.329 ), development of chronic complications ( OR=1.190, 95%CI: 1.027-1.379 ), uncontrolled blood pressure ( OR=1.140, 95%CI: 1.030-1.261 ), uncontrolled blood lipid ( OR=1.258, 95%CI: 1.104-1.433 ), and smoking ( OR=1.318, 95%CI: 1.165-1.491 ) were statistically associated with HbA1c control among T2DM patients. Conclusion The rate of HbA1c control was 47.89% among T2DM patients in rural communities of Zhejiang Province. HbA1c control should be given a high priority among men living in low-economic-level regions with long course of disease, use of hypoglycemic drugs, chronic complications, smoking, uncontrolled blood pressure and lipid.
Key wordstype 2 diabetes mellitus    glycosylated hemoglobin    rural community
收稿日期: 2021-08-26      修回日期: 2021-12-23      出版日期: 2022-02-10
中图分类号:  R587.1  
  R195  
基金资助:国家重点研发计划(2016YFC0901200,2016YFC0901205); 浙江省公益技术应用研究计划(2017C33090)
作者简介: 周晓燕,硕士,医师,主要从事慢性病预防控制工作
通信作者: 胡如英,E-mail:ryhu@cdc.zj.cn   
引用本文:   
周晓燕, 胡如英, 何青芳, 潘劲, 龚巍巍, 陆凤, 王蒙, 钟节鸣. 浙江省农村2型糖尿病患者糖化血红蛋白控制水平及影响因素分析[J]. 预防医学, 2022, 34(2): 123-128.
ZHOU Xiaoyan, HU Ruying, HE Qingfang, PAN Jin, GONG Weiwei, LU Feng, WANG Meng, ZHONG Jieming. Glycosylated hemoglobin control and its influencing factors amongpatients with type 2 diabetes mellitus in rural communitiesof Zhejiang Province. Preventive Medicine, 2022, 34(2): 123-128.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.02.004      或      https://www.zjyfyxzz.com/CN/Y2022/V34/I2/123
[1] International Diabetes Federation.IDF Diabetes Atlas-8th edition[R/OL].2017(2018-11-11)[2021-12-23].http://www.diabetesatlas.org/IDF_Diabetes_Atlas_8e_interactive_EN.
[2] LI Y,TENG D,SHI X,et al.Prevalence of diabetes recorded in mainland China using2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J/OL].BMJ,2020,369(997)[2021-12-23].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186854.DOI:10.1136/bmj.m997.
[3] 邓茜,张梅,黄正京,等.全国疾病监测点35岁及以上糖尿病患者管理现状研究[J].中华流行病学杂志,2016,37(9):1191-1195.
DENG Q,ZHANG M,HUANG Z J,et al.Management of diabetes patients aged ≥35 years in disease areas in China[J].Chin J Epidemiol,2016,37(9):1191-1195.
[4] SPITZ A F,KANANI H.Change in HbAlc as a measure of quality of diabetes care[J].Diabetes Care,2006,29(5):1183-1184.
[5] 陈丽丽,程旻娜,严青华,等.上海市≥35岁自报糖尿病患者血糖控制现状与影响因素分析[J].中国慢性病预防与控制,2018,26(11):818-821.
CHEN L L,CHENG M N,YAN Q H,et al.The diabetes control status and influencing factors among patients with self-reported diabetes(≥35 years old)in Shanghai[J]. Chin J Prev Control Chron Dis,2018,26(11):818-821.
[6] XU F,HE J,WANG Z,et al.The relationship between socio-economic status and diagnosed type 2 diabetes is changing with economic growth in Nanjing,China[J].Diabet Med,2018,35(5):567-575.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398.
Chinese Diabetes Society.Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edtion)[J].Chin J Endocrinol Metab,2021,37(4):311-398.
[8] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
Ministry of Health of the People's Republic of China. Guidelines for the prevention and control of overweight and obesity in adults in China[M].Beijing:People's Medical Press,2006.
[9] 苏健,覃玉,沈冲,等.江苏省社区管理2型糖尿病患者综合控制情况分析[J].中华内分泌杂志,2018,34(2):112-120.
SU J,QIN Y,SHEN C,et al.On the achievement of comprehensive control targets among type 2 diabetic patients managed by communities in Jiangsu province[J]. Chin J Endocrinol Metab,2018,34(2):112-120.
[10] 杨群娣,阮晔,黎衍云,等.上海市社区管理2型糖尿病患者的血糖、血压及血脂控制情况分析[J].中国慢性病预防与控制,2015,23(8):561-564.
YANG Q D,RUAN Y,LI Y Y,et al.The control of blood glucose,blood pressure and blood lipid among type 2 diabetes mellitus patients managed by communities in Shanghai city[J].Chin J Prev Control Chron Dis,2015,23(8):561-564.
[11] 杨群娣,李锐,阮晔,等.上海市2型糖尿病患者的血糖控制的影响因素分析[J].环境与职业医学,2010,27(6):333-336.
YANG Q D,LI R,RUAN Y,et al.Analysis on influencing factors for achieving glycemic control in patients with type 2 diabetes mellitus in Shanghai[J].J Environ Occup Med,2010,27(6):333-336.
[12] 苏华林,孙彦文,黄俊,等.社区糖尿病人血糖控制及影响因素分析[J].疾病控制杂志,2006,10(2):148-150.
SU H L,SUN Y W,HUANG J,et al.Analysis on the blood glucose control and its influencing factors in DM patients in communities[J].Chin J Dis Control Prev,2006,10(2):148-150.
[13] 刘仕俊,袁寒艳,姜彩霞,等.杭州市老年高血压患者血压控制的影响因素研究[J].预防医学,2021,33(7):660-664.
LIU S J,YUAN H Y,JIANG C X,et al.Influencing factors for blood pressure control in elderly patients with hypertension in Hangzhou[J].Prev Med,2021,33(7):660-664.
[14] 胡如英,王勇,何青芳,等.浙江省农村2型糖尿病患者血脂异常及影响因素分析[J].预防医学,2020,32(7):649-654.
HU R Y,WANG Y,HE Q F,et al.Prevalence and influencing factors of dyslipidemia among patients with type 2 diabetes mellitus in rural communities of Zhejiang Province[J].Prev Med,2020,32(7):649-654.
[15] SNOW V,WEISS K B,MOTTUR-PILSON C.The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus[J].Ann Intern Med,2003,138(7):587-592.
[16] VERGES B.Pathophysiology of diabetic dyslipidemia:where are we?[J].Diabetologia,2015,58(5):886-899.
[17] 何静,叶青,王志勇,等.南京市社区2型糖尿病并发高血压患者糖化血红蛋白控制情况及影响因素[J].职业与健康,2018,34(6):847-850.
HE J,YE Q,WANG Z Y,et al.Control status of glycosylated hemoglobin and its influencing factors among type 2 diabetes patients with hypertension in community of Nanjing City[J]. Occup Health,2018,34(6):847-850.
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[3] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[4] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[5] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[6] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[7] 陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[8] 王英杰 综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[9] 孙霞, 但玲英, 郑鹏, 陈薪伊. 2型糖尿病患者脂肪因子与糖尿病视网膜病变的关联研究[J]. 预防医学, 2025, 37(3): 248-252.
[10] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[11] 文进博, 张婷, 赵倩, 刘景, 孙中明, 侯建斌, 陆正权, 许雨婷, 马新雄, 潘恩春. 2型糖尿病患者运动处方干预效果评价[J]. 预防医学, 2025, 37(12): 1211-1216.
[12] 杨丽雅, 杜厉英, 张亚当, 姜灵芝. 2型糖尿病患者西格列汀联合二甲双胍与门冬胰岛素联合二甲双胍干预效果比较[J]. 预防医学, 2025, 37(10): 1054-1058.
[13] 王英杰, 孙高峰, 赵娥, 田原. 2017—2021年乌鲁木齐市2型糖尿病患者管理指标分析[J]. 预防医学, 2025, 37(1): 92-95.
[14] 崔彦泽, 张玲, 蒋璐, 李慧敏, 王硕. 衰弱与2型糖尿病的孟德尔随机化研究[J]. 预防医学, 2024, 36(9): 786-789.
[15] 郑帅印, 李丽丹, 陈佩弟, 谢尔瓦妮古丽·阿卜力米提, 李砥. 2型糖尿病合并非酒精性脂肪肝的预测模型研究[J]. 预防医学, 2024, 36(9): 741-745,749.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed